Safety and Efficacy of Palbociclib (CDK4/6 inhibitor) and Radiotherapy in Metastatic Breast Cancer Patients: Initial Results of a Novel Combination

被引：0
|
作者：
Chowdhary, M. [1 ]
Sen, N. [1 ]
Chowdhary, A. [2 ]
Usha, L. [1 ]
Cobleigh, M. [1 ]
Wang, D. [1 ]
Patel, K. [3 ]
Barry, P. N., Jr. [1 ]
Rao, R. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[3] Yale Sch Med, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2002
引用
收藏
页码：E2 / E2
页数：1
相关论文
共 50 条
  • [41] Glucose Metabolic Reprogramming of ER+ Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib
    Lorito, Nicla
    Bacci, Marina
    Smiriglia, Alfredo
    Mannelli, Michele
    Parri, Matteo
    Comito, Giuseppina
    Ippolito, Luigi
    Giannoni, Elisa
    Bonechi, Martina
    Benelli, Matteo
    Migliaccio, Ilenia
    Malorni, Luca
    Chiarugi, Paola
    Morandi, Andrea
    CELLS, 2020, 9 (03)
  • [42] The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
    Talia, Marianna
    Cirillo, Francesca
    Scordamaglia, Domenica
    Di Dio, Marika
    Zicarelli, Azzurra
    De Rosis, Salvatore
    Miglietta, Anna Maria
    Capalbo, Carlo
    De Francesco, Ernestina Marianna
    Belfiore, Antonino
    Grande, Fedora
    Rizzuti, Bruno
    Occhiuzzi, Maria Antonietta
    Fortino, Giancarlo
    Guzzo, Antonella
    Greco, Gianluigi
    Maggiolini, Marcello
    Lappano, Rosamaria
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [43] Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer
    Sathe, Claire
    Accordino, Melissa K. K.
    DeStephano, David
    Shah, Mansi
    Wright, Jason D. D.
    Hershman, Dawn L. L.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (01) : 85 - 92
  • [44] Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer
    Claire Sathe
    Melissa K. Accordino
    David DeStephano
    Mansi Shah
    Jason D. Wright
    Dawn L. Hershman
    Breast Cancer Research and Treatment, 2023, 200 : 85 - 92
  • [45] A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with "bone-only" metastatic breast cancer
    Tornyi, Ilona
    Arkosy, Peter
    Horvath, Ildiko
    Furka, Andrea
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [46] Efficacy and safety of the CDK4/6 inhibitor palbociclib during different lines of treatment in patients with advanced stage endocrine sensitive/HER2 negative breast cancer.
    Zurcher, Jean-Philippe
    Aedo, Veronica
    Stravodimou, Athina
    Sarivalasis, Apostolos
    Zaman, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Combination CDK4/6 inhibition and AR agonism suppresses the growth of CDK4/6 inhibitor resistant breast cancers
    Freelander, Allegra
    Laven-Law, Geraldine
    Eshraghi, Leila
    Chia, Kee Ming
    Pickering, Marie
    Yong, Aliza
    Wilkinson, Ashleigh
    Alexandrou, Sarah
    Caldon, C. Elizabeth
    Hickey, Theresa E.
    Tilley, Wayne D.
    Lim, Elgene
    CANCER RESEARCH, 2022, 82 (04)
  • [48] Biomarkers for CDK4/6 inhibitor efficacy
    Sorscher, Steven
    BREAST JOURNAL, 2021, 27 (01): : 103 - 103
  • [49] Factors that limit delivery of Cdk4/6 inhibitor palbociclib to GBM
    Parrish, K.
    Pokorny, J.
    Mittapalli, R.
    Bakken, K.
    Sarkaria, J.
    Elmquist, W.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 86 - 86
  • [50] Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
    Patnaik, Amita
    Rosen, Lee S.
    Tolaney, Sara M.
    Tolcher, Anthony W.
    Goldman, Jonathan W.
    Gandhi, Leena
    Papadopoulos, Kyriakos P.
    Beeram, Muralidhar
    Rasco, Drew W.
    Hilton, John F.
    Nasir, Aejaz
    Beckmann, Richard P.
    Schade, Andrew E.
    Fulford, Angie D.
    Nguyen, Tuan S.
    Martinez, Ricardo
    Kulanthaivel, Palaniappan
    Li, Lily Q.
    Frenzel, Martin
    Cronier, Damien M.
    Chan, Edward M.
    Flaherty, Keith T.
    Wen, Patrick Y.
    Shapiro, Geoffrey I.
    CANCER DISCOVERY, 2016, 6 (07) : 740 - 753
12345